Financhill
Buy
61

VRTX Quote, Financials, Valuation and Earnings

Last price:
$503.04
Seasonality move :
11.16%
Day range:
$488.00 - $512.75
52-week range:
$377.85 - $519.88
Dividend yield:
0%
P/E ratio:
26.10x
P/S ratio:
11.66x
P/B ratio:
7.75x
Volume:
1.4M
Avg. volume:
1.5M
1-year change:
21.71%
Market cap:
$127.2B
Revenue:
$11B
EPS (TTM):
-$2.20

Earnings Data

Next earnings date for VRTX
May 06
2025
Most recent earnings per share
$3.50
Missed by $0.52
(Feb 10/2025)
Consensus Estimate
$4.02
(Feb 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VRTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/06/2025 Q1 $2.9B -- -- $4.32 --
02/10/2025 Q4 $2.8B $2.9B $3.50 $4.02 -$0.52
11/04/2024 Q3 $2.7B $2.8B $4.01 $4.13 -$0.12
08/01/2024 Q2 $2.7B $2.6B -$13.92 -$11.75 -$2.17
05/06/2024 Q1 $2.6B $2.7B $4.21 $4.06 $0.15
02/05/2024 Q4 $2.5B $2.5B $3.71 $4.09 -$0.38
11/06/2023 Q3 -- -- $3.97 $3.97 -$0.00
08/01/2023 Q2 -- -- $3.52 $3.88 -$0.36
05/01/2023 Q1 -- -- $2.69 $3.00 -$0.31
02/07/2023 Q4 -- -- $3.15 $3.51 -$0.36
10/27/2022 Q3 -- -- $3.59 $3.64 -$0.05
08/04/2022 Q2 -- -- $3.13 $3.50 -$0.37
05/05/2022 Q1 -- -- $2.96 $3.54 -$0.58
01/26/2022 Q4 -- -- $3.00 $3.29 -$0.29
11/02/2021 Q3 -- -- $3.28 $3.06 $0.22
07/29/2021 Q2 -- -- $0.26 $2.38 -$2.12
04/29/2021 Q1 -- -- $2.49 $2.69 -$0.20
02/01/2021 Q4 -- -- $2.30 $2.55 -$0.25
10/29/2020 Q3 -- -- $2.53 $2.33 $0.20
07/30/2020 Q2 -- -- $3.18 $2.08 $1.10
04/29/2020 Q1 -- -- $2.29 $1.85 $0.44
01/30/2020 Q4 -- -- $2.23 $1.22 $1.01
10/30/2019 Q3 -- -- $0.22 $1.16 -$0.94
07/31/2019 Q2 -- -- $1.26 $1.07 $0.19
04/30/2019 Q1 -- -- $1.14 $1.01 $0.13
02/05/2019 Q4 -- -- $1.30 $1.06 $0.24
10/24/2018 Q3 -- -- $1.09 $1.01 $0.08
07/25/2018 Q2 -- -- $0.94 $0.75 $0.19
04/26/2018 Q1 -- -- $0.76 $0.63 $0.13
01/31/2018 Q4 -- -- $0.61 $0.54 $0.07
10/25/2017 Q3 -- -- $0.53 $0.37 $0.16
07/26/2017 Q2 -- -- $0.39 $0.36 $0.03
04/27/2017 Q1 -- -- $1.33 $1.13 $0.20
01/25/2017 Q4 -- -- $0.13 -- --
10/25/2016 Q3 -- -- -- -- --
07/27/2016 Q2 -- -- -- -- --
04/27/2016 Q1 -- -- -- $0.04 --
01/27/2016 Q4 -- -- -- -- --
10/28/2015 Q3 -- -- -- -- --
07/29/2015 Q2 -- -- -- -- --
04/29/2015 Q1 -- -- -- -- --

Vertex Pharmaceuticals Earnings Questions

  • How Much did Vertex Pharmaceuticals Generate in Revenue Last Quarter?

    Vertex Pharmaceuticals reported $2.9B worth of top line sales in its most recent quarter.

  • Did Vertex Pharmaceuticals Beat Earnings Last Quarter?

    Vertex Pharmaceuticals announced earnings per share of $3.50 which represents a miss of analyst forecast a $4.02 per share.

  • Is Vertex Pharmaceuticals Profitable?

    Vertex Pharmaceuticals reported $2.5B that represents $9.67 per share over the last quarter.

  • What is the Analyst Consensus for Vertex Pharmaceuticals EPS Next Year?

    Vertex Pharmaceuticals's earnings are forecast to decrease from -$2.08 per share to $0.49 per share next year representing a decrease of -96.5%.

  • When is Vertex Pharmaceuticals's Earnings Date?

    Vertex Pharmaceuticals's next earnings date is May 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

3 Safest Stocks to Buy Now
3 Safest Stocks to Buy Now

With the S&P 500 now in correction and stocks selling…

Tesla Stock: The Bear Case
Tesla Stock: The Bear Case

The recent stock market drop has been a punishing time…

Is VUG a Good ETF to Buy?
Is VUG a Good ETF to Buy?

For the last few years, earnings growth from the tech…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Sell
47
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Alerts

Sell
5
CABO alert for Mar 14

Cable One [CABO] is down 14.08% over the past day.

Sell
38
ADBE alert for Mar 14

Adobe [ADBE] is down 13.89% over the past day.

Sell
29
CAR alert for Mar 14

Avis Budget Group [CAR] is down 11.48% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock